These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2429367)

  • 1. Interferons in the treatment of multiple myeloma.
    Cooper MR; Welander CE
    Semin Oncol; 1986 Sep; 13(3):334-40. PubMed ID: 2429367
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interferon in the treatment of multiple myeloma].
    Kuzmits R; Ludwig H; Cortelezzi A; Van Camp BG; Polli E; Flener R; Scheithauer W
    Acta Med Austriaca; 1985; 12(5):135-8. PubMed ID: 3914174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferons in the treatment of multiple myeloma.
    Cooper MR; Welander CE
    Cancer; 1987 Feb; 59(3 Suppl):594-600. PubMed ID: 3802025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferons in the treatment of multiple myeloma.
    Cooper MR
    Semin Oncol; 1986 Sep; 13(3 Suppl 2):13-20. PubMed ID: 3764441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melphalan-resistant multiple myeloma: results of treatment according to the M-2 protocol.
    Steinke B; Busch FW; Becherer C; Ostendorf P; Waller HD
    Cancer Chemother Pharmacol; 1985; 14(3):279-81. PubMed ID: 3838922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic strategies and controversies in the treatment of multiple myeloma.
    Bladé J
    Pathol Biol (Paris); 1999 Feb; 47(2):192-8. PubMed ID: 10192888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferons in the management of multiple myeloma.
    Cooper MR
    Semin Oncol; 1988 Oct; 15(5 Suppl 5):21-5. PubMed ID: 3057642
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of refractory multiple myeloma and considerations for future therapy.
    Kyle RA; Greipp PR; Gertz MA
    Semin Oncol; 1986 Sep; 13(3):326-33. PubMed ID: 3532331
    [No Abstract]   [Full Text] [Related]  

  • 9. [Monoclonal gammapathy of indeterminate origin and myeloma].
    Bury J; Salmon J; Fillet G
    Rev Med Liege; 1988 Apr; 43(8):270-4. PubMed ID: 3285431
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis and management of multiple myeloma.
    UK myeloma forum. British Committee for Standards in Haematology
    Br J Haematol; 2001 Dec; 115(3):522-40. PubMed ID: 11736932
    [No Abstract]   [Full Text] [Related]  

  • 11. Results and further perspectives of plasmocytoma chemotherapy.
    Sakalová A; Hrubisko M; Gazová S; Steruská M; Prümmerová J
    Neoplasma; 1986; 33(2):251-8. PubMed ID: 3520353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of multiple myeloma. Italian Multiple Myeloma Study Group.
    Boccadoro M; Avvisati G; Cantonetti M; Cavo-Comotti BM; Frieri R; Gallamini A; Gallone G; Lauta VM; Liberati M; Marmont F
    Pathol Biol (Paris); 1990 Oct; 38(8):829. PubMed ID: 2274374
    [No Abstract]   [Full Text] [Related]  

  • 13. The therapy of multiple myeloma with the interferons.
    Bonnem EM
    Cancer Treat Rev; 1988 Jan; 15 Suppl A():35-41. PubMed ID: 2449280
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferon alfa-2b/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trial.
    Cooper MR; Fefer A; Thompson J; Case DC; Kempf R; Sacher R; Neefe J; Bickers J; Scarffe JH; Spiegel RJ
    Invest New Drugs; 1987; 5 Suppl():S41-6. PubMed ID: 3597002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide, doxorubicin, prednisone and vindesine combination chemotherapy in melphalan-resistant multiple myeloma.
    Van Dobbenburgh OA; Houwen B; Piersma H; Marrink J; Ockhuizen T; Halie MR; Nieweg HO
    Neth J Med; 1984; 27(2):25-30. PubMed ID: 6709108
    [No Abstract]   [Full Text] [Related]  

  • 16. [Interferon: a new weapon in the therapeutic strategy of multiple myeloma].
    Avvisati G; Petrucci MT; Mandelli F
    Haematologica; 1990; 75 Suppl 4():68-71. PubMed ID: 1705913
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combination chemotherapy (modified M-2 protocol) for multiple myeloma].
    Iwata Y; Karitani Y; Tanaka I; Kobayashi T; Ohno T; Kageyama S; Katayama N; Kataoka Y; Kamio N; Ohota C
    Rinsho Ketsueki; 1984 Sep; 25(9):1380-7. PubMed ID: 6549187
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination chemotherapy versus melphalan and prednisone in multiple myeloma.
    Gruber A; Osby E
    Chemioterapia; 1987 Jun; 6(2 Suppl):725-6. PubMed ID: 3509531
    [No Abstract]   [Full Text] [Related]  

  • 19. [Possibility of using interferon in the treatment of multiple myeloma].
    Piatkowska-Jakubas B; Skotnicki AB; Blicharski J
    Przegl Lek; 1988; 45(10):747-50. PubMed ID: 3072590
    [No Abstract]   [Full Text] [Related]  

  • 20. Mutiple myeloma resistant to melphalan (NSC-8806) treated with cyclophosphamide (NSC-26271), prednisone (NSC-10023), and chloroquine (NSC-187208).
    Kyle RA; Seligman BR; Wallace HJ; Silver RT; Glidewell O; Holland JF
    Cancer Chemother Rep; 1975; 59(3):557-62. PubMed ID: 1203882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.